Published in Blood Weekly, January 18th, 2007
The company will use the funds to bring new molecular diagnostics to the market to enable fast identification and simple monitoring of sepsis often a deadly disease.
Sepsis, also called blood poisoning, is the second most frequent cause of death in hospitals after cardiovascular diseases. With about two million cases worldwide out of which approximately 50% die, sepsis remains one of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.